Increasing Geriatric Population Needing More and More Orthopedic Biomaterials

The orthopedic biomaterials market had a value of above $14 billion in 2021, and it will advance at a growth rate of about 10% in the coming years, to reach above $32 billion by 2030. The reconstructive joint replacements had the largest demand in 2021, with revenue of above $4 billion, and it would grow at a significant growth rate of above 9%, in the future. This is for the reason that the occurrence of severe damage and late-stage osteoarthritis is quickly increasing.

The hospitals had the largest demand of approximately, 42%. In many nations, hospital admissions and patients visiting for orthopedic procedures have significantly increased over the past twenty-thirty years. Patients generally like to be treated at hospitals since contemporary therapeutic approaches are available here.

The rise in musculoskeletal problems will boost the growth of the orthopedic biomaterials market. Musculoskeletal ailments are the main causes of disability worldwide, according to research, with these disabilities upsetting 20-30% of people. Fractures, inflammation, and pain in the joints, ligaments, and tendons are the prevalent musculoskeletal issues resulting in constrained mobility.

North America has the highest demand for orthopedics biomaterials and will grow at a significant rate in the coming years. This is due to the increase in the volume of patients experiencing knee reconstruction and replacement and other treatments.

APAC will grow at the fastest rate of 10%, in the near future. The growing number of cases of musculoskeletal ailments, like bone degenerative illnesses, in evolving nations is one of the important reasons helping the regional industry to grow. Furthermore, the surging healthcare spending, along with the developments in the healthcare infra will have a positive impact on the demand for orthopedic biomaterials in this region.

The increasing geriatric population and the increasing cases of people having musculoskeletal conditions have a positive impact on the demand for orthopedic biomaterials.

Read More

How Does Emerging Economies Impact Medical Polyether Ether Ketone Market?

The medical polyether ether ketone market generated $582.4 million in 2021, and it is expected to rise to $1,146.6 million in 2030, advancing at a rate of 7.8% from 2021 to 2030, ascribed to the massive replacement of the metallic implants made from PEEK, due to increasing government funding to healthcare services and the emergence of private players.

Moreover, high-performance plastic garners have a high preference among materials for trauma fixation, dental implants, cardiovascular devices, and numerous other applications. In addition, the rise in the geriatric population in Asian, North American, and European countries, along with rising sports injuries are expected to boost the market.

The rapid industrialization, and increase in the research activities in the developing countries, more preferably in the APAC region boost the medical polyether ether ketone market, due to an increase in the manufacturing of PEEK-based medical products. In addition, the major players in the market are focusing on a range of strategic plans for business development, such as investments, partnerships, and product launches to advance their position in the market. Thus, it has resulted in high-grade polymers for devices & medical implants.

North America contributes significant revenue to the medical PEEK market, ascribed to the expansion of healthcare facilities, and innovations in medical devices. Moreover, the surging requirement for stents, heart valves, spine implants, and knee and hip implants led by the growing population in the country, results in an increase in medical-grade plastics usage. 

Moreover, the penetration of the medical devices and component manufacturers that utilize PEEK in the country boosts the market. Along with this, the presence of major manufacturing companies in the U.S. drives the region’s market. 

Therefore, the increasing use of PEEK as titanium substituent in dental implants and prevalence of the cardiac diseases propel the market.

Read More